Bionano Genomics, Inc. Stock-Based Compensation
Bionano Genomics, Inc. (BNGO) reported Stock-Based Compensation of $1.64 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-10
- Bionano Genomics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $970.00K, a 10.19% decline year-over-year.
- Bionano Genomics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $670.00K, a 57.78% decline year-over-year.
- Bionano Genomics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $926.00K, a 52.17% decline year-over-year.
- Bionano Genomics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $941.00K, a 57.27% decline year-over-year.
- Bionano Genomics, Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $4.53M, a 53.43% decline from fiscal 2024.
- Bionano Genomics, Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $9.74M, a 35.85% decline from fiscal 2023.
- Bionano Genomics, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $15.18M, a 32.29% decline from fiscal 2022.
- Bionano Genomics, Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $22.42M, a 130.65% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $970.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $1.64M 10-Q · filed 2026-08-10 | $2.57M derived: sum of 3 quarters · filed 2026-08-10 | $3.51M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2026-03-31 | $670.00K 10-Q · filed 2026-05-13 | $1.60M derived: sum of 2 quarters · filed 2026-05-13 | $2.54M derived: sum of 3 quarters · filed 2026-05-13 | $3.62M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-12-31 | $926.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $1.87M derived: sum of 2 quarters · filed 2026-03-23 | $2.95M derived: sum of 3 quarters · filed 2026-08-10 | $4.53M 10-K · filed 2026-03-23 | ||||
| 2025-09-30 | $941.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $2.02M derived: sum of 2 quarters · filed 2026-08-10 | $3.61M 10-Q · filed 2025-11-13 | $5.54M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-06-30 | $1.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $2.67M 10-Q · filed 2026-08-10 | $4.60M derived: sum of 3 quarters · filed 2026-08-10 | $6.80M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-03-31 | $1.59M 10-Q · filed 2026-05-13 | $3.52M derived: sum of 2 quarters · filed 2026-05-13 | $5.72M derived: sum of 3 quarters · filed 2026-05-13 | $8.31M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $1.94M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $4.14M derived: sum of 2 quarters · filed 2026-03-23 | $6.72M derived: sum of 3 quarters · filed 2026-03-23 | $9.74M 10-K · filed 2026-03-23 | ||||
| 2024-09-30 | $2.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $4.79M derived: sum of 2 quarters · filed 2025-11-13 | $7.80M 10-Q · filed 2025-11-13 | $11.17M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | $2.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $5.60M 10-Q · filed 2025-08-14 | $8.97M derived: sum of 3 quarters · filed 2025-08-14 | $12.96M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $3.02M 10-Q · filed 2025-05-14 | $6.39M derived: sum of 2 quarters · filed 2025-05-14 | $10.38M derived: sum of 3 quarters · filed 2025-05-14 | $14.31M derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | $3.37M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $7.36M derived: sum of 2 quarters · filed 2025-03-31 | $11.30M derived: sum of 3 quarters · filed 2025-03-31 | $15.18M 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | $3.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $7.92M derived: sum of 2 quarters · filed 2024-11-14 | $11.81M 10-Q · filed 2024-11-14 | $17.29M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $3.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $7.81M 10-Q · filed 2024-08-07 | $13.29M derived: sum of 3 quarters · filed 2024-08-07 | $19.35M derived: sum of 4 quarters · filed 2024-08-07 | ||||
| 2023-03-31 | $3.88M 10-Q · filed 2024-05-08 | $9.36M derived: sum of 2 quarters · filed 2024-05-08 | $15.42M derived: sum of 3 quarters · filed 2024-05-08 | $21.20M derived: sum of 4 quarters · filed 2024-05-08 | ||||
| 2022-12-31 | $5.48M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $11.54M derived: sum of 2 quarters · filed 2024-03-05 | $17.32M derived: sum of 3 quarters · filed 2024-03-05 | $22.42M 10-K · filed 2024-03-05 | ||||
| 2022-09-30 | $6.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $11.84M derived: sum of 2 quarters · filed 2023-11-08 | $16.94M 10-Q · filed 2023-11-08 | $21.74M derived: sum of 4 quarters · filed 2023-11-08 | ||||
| 2022-06-30 | $5.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $10.88M 10-Q · filed 2023-08-09 | $10.88M 10-Q · filed 2022-08-04 | $15.68M derived: sum of 3 quarters · filed 2023-08-09 | $18.47M derived: sum of 4 quarters · filed 2023-08-09 | |||
| 2022-03-31 | $5.10M 10-Q · filed 2023-05-09 | $9.90M derived: sum of 2 quarters · filed 2023-05-09 | $12.69M derived: sum of 3 quarters · filed 2023-05-09 | $14.45M derived: sum of 4 quarters · filed 2023-05-09 | ||||
| 2021-12-31 | $4.80M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $7.59M derived: sum of 2 quarters · filed 2023-03-09 | $9.35M derived: sum of 3 quarters · filed 2023-03-09 | $9.72M 10-K · filed 2023-03-09 | ||||
| 2021-09-30 | $2.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $4.55M derived: sum of 2 quarters · filed 2022-11-03 | $4.92M 10-Q · filed 2022-11-03 | $5.37M derived: sum of 4 quarters · filed 2022-11-03 | ||||
| 2021-06-30 | $1.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $2.13M 10-Q · filed 2022-08-04 | $2.58M derived: sum of 3 quarters · filed 2022-08-04 | $3.03M derived: sum of 4 quarters · filed 2022-08-04 | ||||
| 2021-03-31 | $371.00K 10-Q · filed 2022-05-05 | $822.00K derived: sum of 2 quarters · filed 2022-05-05 | $1.27M derived: sum of 3 quarters · filed 2022-05-05 | $1.60M derived: sum of 4 quarters · filed 2022-05-05 | ||||
| 2020-12-31 | $451.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $898.00K derived: sum of 2 quarters · filed 2022-03-01 | $1.23M derived: sum of 3 quarters · filed 2022-03-01 | $1.55M 10-K · filed 2022-03-01 | $1.55M 10-K · filed 2021-03-23 | |||
| 2020-09-30 | $447.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $775.00K derived: sum of 2 quarters · filed 2021-11-04 | $1.10M 10-Q · filed 2021-11-04 | $1.46M derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2020-06-30 | $328.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $656.00K 10-Q · filed 2021-08-04 | $1.01M derived: sum of 3 quarters · filed 2021-08-04 | $1.38M derived: sum of 4 quarters · filed 2021-08-04 | ||||
| 2020-03-31 | $328.00K 10-Q · filed 2021-05-13 | $684.02K derived: sum of 2 quarters · filed 2021-05-13 | $1.05M derived: sum of 3 quarters · filed 2021-05-13 | $1.39M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | $356.02K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23 | $721.02K derived: sum of 2 quarters · filed 2021-03-23 | $1.06M derived: sum of 3 quarters · filed 2021-03-23 | $1.35M 10-K · filed 2021-03-23 | ||||
| 2019-09-30 | $365.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $701.00K derived: sum of 2 quarters · filed 2020-11-13 | $990.00K 10-Q · filed 2020-11-13 | $989.52K 10-Q · filed 2019-11-07 | $2.02M derived: sum of 4 quarters · filed 2020-11-13 | |||
| 2019-06-30 | $336.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $625.00K 10-Q · filed 2020-08-13 | $625.06K 10-Q · filed 2019-08-08 | $1.66M derived: sum of 3 quarters · filed 2020-08-13 | $1.71M derived: sum of 4 quarters · filed 2020-08-13 | |||
| 2019-03-31 | $289.00K 10-Q · filed 2020-06-18 | $289.39K 10-Q · filed 2019-05-09 | $1.32M derived: sum of 2 quarters · filed 2020-06-18 | $1.38M derived: sum of 3 quarters · filed 2020-06-18 | $1.43M derived: sum of 4 quarters · filed 2020-06-18 | |||
| 2018-12-31 | $1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $1.09M derived: sum of 2 quarters · filed 2020-03-10 | $1.14M derived: sum of 3 quarters · filed 2020-03-10 | $1.19M 10-K · filed 2020-03-10 | ||||
| 2018-09-30 | $53.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $106.11K derived: sum of 2 quarters · filed 2019-11-07 | $160.55K 10-Q · filed 2019-11-07 | $301.41K derived: sum of 4 quarters · filed 2019-11-07 | ||||
| 2018-06-30 | $52.98K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $107.43K 10-Q · filed 2019-08-08 | $248.28K derived: sum of 3 quarters · filed 2019-08-08 | |||||
| 2018-03-31 | $54.44K 10-Q · filed 2019-05-09 | $195.30K derived: sum of 2 quarters · filed 2019-05-09 | ||||||
| 2017-12-31 | $140.86K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $382.83K 10-K · filed 2019-03-14 | ||||||
| 2017-09-30 | $241.97K 10-Q · filed 2018-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |